Disclosures for "Effectiveness of Cenobamate in Patients with Epileptic Encephalopathies: Analysis of a Single-center Cohort"
-
Dr. Sanikommu has nothing to disclose.
-
Dr. Costas Encarnacion has nothing to disclose.
-
Ms. Eatz has nothing to disclose.
-
Dr. Millan has nothing to disclose.
-
Dr. Kanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Kanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon. Dr. Kanner has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsy Foundation of America. Dr. Kanner has received personal compensation in the range of $500-$4,999 for serving as a Lecture at International meeting with Eisai.